2,2900
04-октября-24 15:59:59
15 мин. задержка
Акции
-0,0200
-0,87%
Сегодняшний диапазон
2,2900 - 2,4200
ISIN
N/A
Источник
NASDAQ
Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity
12 мар 2024 08:38:26 Источник Nasdaq GlobeNewswire
Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials
20 фев 2024 08:38:00 Источник Nasdaq GlobeNewswire